Givaudan Valuation

Is 0QPS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QPS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QPS (CHF3930) is trading above our estimate of fair value (CHF3795.68)

Significantly Below Fair Value: 0QPS is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QPS?

Key metric: As 0QPS is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QPS. This is calculated by dividing 0QPS's market cap by their current earnings.
What is 0QPS's PE Ratio?
PE Ratio35.2x
EarningsCHF 1.03b
Market CapCHF 36.16b

Price to Earnings Ratio vs Peers

How does 0QPS's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QPS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.4x
CRDA Croda International
30.4x15.1%UK£4.8b
JMAT Johnson Matthey
23.8x28.4%UK£2.5b
VCT Victrex
24.9x37.8%UK£750.5m
TET Treatt
22.6x15.3%UK£254.1m
0QPS Givaudan
35.2x6.1%CHF 36.2b

Price-To-Earnings vs Peers: 0QPS is expensive based on its Price-To-Earnings Ratio (35.2x) compared to the peer average (25.4x).


Price to Earnings Ratio vs Industry

How does 0QPS's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0QPS 35.2xIndustry Avg. 16.8xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QPS is expensive based on its Price-To-Earnings Ratio (35.2x) compared to the European Chemicals industry average (16.8x).


Price to Earnings Ratio vs Fair Ratio

What is 0QPS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QPS PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio35.2x
Fair PE Ratio18.1x

Price-To-Earnings vs Fair Ratio: 0QPS is expensive based on its Price-To-Earnings Ratio (35.2x) compared to the estimated Fair Price-To-Earnings Ratio (18.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QPS forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 3,930.00
CHF 4,186.25
+6.5%
10.7%CHF 5,100.00CHF 3,330.00n/a20
Nov ’25CHF 4,125.80
CHF 4,203.57
+1.9%
10.2%CHF 5,100.00CHF 3,330.00n/a21
Oct ’25CHF 4,656.30
CHF 4,159.00
-10.7%
9.9%CHF 4,934.00CHF 3,200.00n/a22
Sep ’25CHF 4,356.00
CHF 4,094.82
-6.0%
10.9%CHF 4,852.00CHF 3,000.00n/a22
Aug ’25CHF 4,307.00
CHF 4,094.82
-4.9%
10.9%CHF 4,852.00CHF 3,000.00n/a22
Jul ’25CHF 4,279.00
CHF 3,976.95
-7.1%
11.5%CHF 4,800.00CHF 3,000.00n/a21
Jun ’25CHF 4,206.00
CHF 3,840.90
-8.7%
12.1%CHF 4,700.00CHF 2,800.00n/a21
May ’25CHF 3,946.00
CHF 3,805.00
-3.6%
11.8%CHF 4,700.00CHF 2,800.00n/a21
Apr ’25CHF 4,003.07
CHF 3,613.50
-9.7%
13.1%CHF 4,600.00CHF 2,800.00n/a21
Mar ’25CHF 3,713.00
CHF 3,404.02
-8.3%
11.1%CHF 4,160.00CHF 2,800.00n/a21
Feb ’25CHF 3,581.93
CHF 3,337.12
-6.8%
10.1%CHF 4,000.00CHF 2,750.00n/a21
Jan ’25CHF 3,480.00
CHF 3,201.78
-8.0%
10.7%CHF 4,000.00CHF 2,600.00n/a20
Dec ’24CHF 3,303.00
CHF 3,158.78
-4.4%
11.3%CHF 4,000.00CHF 2,500.00n/a20
Nov ’24CHF 3,028.02
CHF 3,167.83
+4.6%
12.4%CHF 4,100.00CHF 2,500.00CHF 4,125.8021
Oct ’24CHF 2,994.00
CHF 3,164.36
+5.7%
12.5%CHF 4,100.00CHF 2,500.00CHF 4,656.3021
Sep ’24CHF 2,929.00
CHF 3,120.98
+6.6%
13.3%CHF 4,100.00CHF 2,400.00CHF 4,356.0022
Aug ’24CHF 2,936.00
CHF 3,153.24
+7.4%
13.4%CHF 4,100.00CHF 2,400.00CHF 4,307.0023
Jul ’24CHF 2,943.09
CHF 3,142.15
+6.8%
13.2%CHF 4,100.00CHF 2,400.00CHF 4,279.0024
Jun ’24CHF 3,021.44
CHF 3,138.39
+3.9%
13.4%CHF 4,100.00CHF 2,400.00CHF 4,206.0023
May ’24CHF 3,100.31
CHF 3,138.39
+1.2%
13.4%CHF 4,100.00CHF 2,400.00CHF 3,946.0023
Apr ’24CHF 2,899.75
CHF 3,081.52
+6.3%
15.6%CHF 4,100.00CHF 2,039.40CHF 4,003.0724
Mar ’24CHF 2,821.90
CHF 3,081.02
+9.2%
15.8%CHF 4,100.00CHF 2,039.40CHF 3,713.0023
Feb ’24CHF 2,978.44
CHF 3,086.45
+3.6%
16.1%CHF 4,150.00CHF 2,039.40CHF 3,581.9323
Jan ’24CHF 2,833.00
CHF 3,207.52
+13.2%
17.4%CHF 4,200.00CHF 2,039.40CHF 3,480.0022
Dec ’23CHF 3,184.32
CHF 3,217.52
+1.0%
17.4%CHF 4,200.00CHF 2,039.40CHF 3,303.0022
Nov ’23CHF 2,948.14
CHF 3,281.28
+11.3%
18.5%CHF 4,200.00CHF 2,039.40CHF 3,028.0223

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies